7MM cancer cachexia market eyes 8.9% CAGR growth through 2034

Thanks to the introduction of new therapies.

The cancer cachexia market across seven major markets (7MM) is expected to expand at a compound annual growth rate of 8.9% until 2034, said DelveInsight.

The sector’s growth is driven by the emergence of new therapies, along with the rising prevalence of the condition, increasing incidence of high-risk tumour types, and improved diagnostic awareness.

Cancer cachexia, a multifactorial wasting disorder observed in advanced stages of cancer, is characterised by a progressive depletion of skeletal muscle and fat.

“Potential therapies are being investigated for the treatment of cancer cachexia, and it is safe to predict that the treatment space will significantly impact the cancer cachexia market during the forecast period,” the report said.

7MM = US, Germany, France, Italy, Spain, UK, and Japan.